Home | HAB Central

Honoraria Payments

Did you participate in a research study?

To retrieve your honoraria, click the sign-in link.from the menu at the top right of the page.

Article of the Day

FDA Approves Setmelanotide for Treating Obesity Due to Rare Genetic Conditions

The US Food and Drug Administration (FDA) approved setmelanotide (Imcivree) for chronic weight management (weight loss and weight maintenance for at least 1 year) in patients aged 6 years and older with obesity due to 3 rare genetic conditions: pro-opiomelanocortin (POMC) deficiency, proprotein...

See more articles

Journal Club

Rheumatology

High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study

Nowak, Rdzanek-Pikus, Romanowska-Próchnicka, et al.

Future Microbiology

Cerebrospinal fluid microscopy as an index for predicting the prognosis of cryptococcal meningitis patients with and without HIV

Zhang, Li, Zhang, et al.

See more abstracts

CME

Credits: 1.25 CME

Vindico

Influenza in the Hospital: Perils and Pearls

Christopher S. Kim, MD, MBA, SFHM

Credits: 0.75 CME

Oakstone Publishing

Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?

Per-Henrik Groop, MD, DMSc, FRCPE

See more education

HAB Central Earn honoraria and learn developments in medicine. For more than 25 years, the Healthcare Advisors Bureau (HAB) has gathered the opinions of professional healthcare providers.

Through HAB, the world of medicine has a respected and influential voice with government bodies, institutions, publishers, product manufacturers and providers of healthcare services.